Retatrutide works on additional metabolic pathways and may offer stronger results with fewer side effects for some patients
Research into the efficacy of GLP-1 drugs found that, in a clinical trial setting, Semaglutide (Ozempic and Wegovy) could result in a 14.9% reduction in body weight over the course of 68 weeks
Ozempic, Mounjaro, and Rybelsus are approved for type 2 diabetes, so prescribing them for weight loss is an off-label use
Regular exercise: Aerobic activity in particular has been shown to raise GLP-1 levels, and those elevated levels can persist for up to 24 hours after a workout
With insurance coverage (where available), copays can range from $25 to several hundred dollars depending on the plan
For 0.5 mg: 0.5 / 5 = 0.1 mL = 10 units